Dental Plaque Removal Efficacy Evaluation: Standards, Methods, and Laboratory Testing

Dental plaque removal efficacy evaluation is a laboratory and clinical testing process that objectively measures how effectively oral care products—such as manual and powered toothbrushes, toothpastes, mouthrinses, and interdental cleaners—eliminate plaque biofilm from tooth surfaces. Accredited third-party laboratories perform these assessments in accordance with internationally recognized standards, including ISO 20126, ISO 20127, ISO 11609, and ISO/TS 16409, giving manufacturers defensible data for regulatory compliance and marketing claims. This guide explains the testing scope, sample requirements, evaluation methods, and typical applications of plaque removal efficacy assessment.

Technical Overview

Dental plaque is a structurally organized biofilm composed of bacterial communities embedded in an extracellular polysaccharide matrix that adheres tenaciously to enamel, gingival margins, and interproximal surfaces. When plaque is not effectively disrupted, it mineralizes into calculus and becomes the primary etiological factor in caries, gingivitis, and periodontal disease. Because regulators, retailers, and consumers increasingly demand objective evidence for "plaque removal" and "clinically proven" claims, manufacturers rely on structured efficacy evaluation to substantiate product performance before market launch.

Plaque removal efficacy evaluation generally follows a two-tier framework. Laboratory (in vitro) methods use standardized artificial biofilms cultured on hydroxyapatite discs, bovine enamel slabs, or typodont models to screen product designs and formulations rapidly, reproducibly, and at controlled cost. Clinical methods then verify real-world performance in human subjects using disclosing agents and internationally accepted plaque indices. Both tiers are supported by recognized standards, including ISO 20126 for manual toothbrushes, ISO 20127 for powered toothbrushes, ISO 11609 for toothpastes, and ISO/TS 16409 for in vitro biofilm removal testing, together with applicable GB requirements such as GB 19342 for toothbrushes and GB/T 8372 for toothpastes in the Chinese market.

Accredited third-party laboratories conduct these evaluations under documented quality management systems, with calibrated brushing apparatus, traceable microbiological procedures, blinded clinical examination, and statistically rigorous data analysis. The resulting test reports serve as independent technical evidence for product registration, e-commerce platform onboarding, and advertising claim substantiation.

Testing Samples

Manual Toothbrushes

Finished retail products are submitted in sealed, unopened packaging, typically 20 to 60 units depending on the test design. Key documented parameters include bristle material, filament diameter, tuft density, end-rounding classification, and handle geometry, as these factors directly influence cleaning performance under ISO 20126 test conditions.

Powered and Sonic Toothbrushes

Complete devices should be provided with chargers, interchangeable brush heads, and user instructions, generally 10 to 30 sets plus sufficient replacement heads for repeated test cycles. Technical specifications such as oscillation frequency, sonic amplitude, and operating modes must be documented so the laboratory can replicate defined use conditions per ISO 20127.

Toothpastes and Toothpowders

Sealed retail units from a single production batch, typically 20 to 40 tubes or sachets, are required along with the full ingredient declaration and abrasivity data where available. Formulation type (fluoride, herbal, whitening, sensitive) determines which cleaning and safety endpoints are evaluated under ISO 11609.

Mouthrinses and Oral Sprays

Liquid products are submitted in finished retail packaging, generally 20 to 30 bottles, with active ingredient concentrations and recommended dosing instructions. Antimicrobial and anti-adhesion mechanisms are assessed through biofilm disruption and regrowth inhibition studies.

Interdental Cleaners and Oral Irrigators

Dental floss, interdental brushes, and powered oral irrigators require 20 to 40 consumer units or refills. Interproximal cleaning performance is emphasized because this region is inaccessible to conventional toothbrush filaments and represents the most clinically significant plaque accumulation site.

Plaque Disclosing Products

Disclosing tablets and solutions may be evaluated both as products in their own right, for staining sensitivity and removability, and as measurement tools that support quantitative image analysis in clinical trials.

Testing Items

Depending on product category and regulatory objective, a typical evaluation program covers the following endpoints:

• Whole-mouth plaque removal rate (percentage reduction before and after a controlled brushing cycle)
• Plaque index reduction using the Turesky modification of the Quigley–Hein index, the Silness–Löe index, or the Navy plaque index
• Interproximal and gingival-margin cleaning scores, reflecting access to difficult-to-reach zones
• In vitro artificial biofilm removal rate on hydroxyapatite, bovine enamel, or acrylic substrates
• Residual viable biomass (colony-forming unit counts) and total biomass (crystal violet or fluorescence quantification)
• Cleaning consistency across tooth-surface zones, including buccal, lingual, palatal, and occlusal areas
• Comparative performance against a reference or control product, with statistical superiority or non-inferiority conclusions
• Soft-tissue safety observations, including gingival abrasion and mucosal irritation during use
• Dentin and enamel abrasiveness for abrasive formulations, assessed as radioactive or relative dentin abrasivity per ISO 11609

Testing Methods

In Vitro Artificial Biofilm Removal

Standardized biofilms are cultured on hydroxyapatite discs or bovine enamel slabs using single-species or multispecies models, commonly involving Streptococcus mutans, Streptococcus sanguinis, and Actinomyces naeslundii in sucrose-supplemented medium over 48 to 72 hours. Specimens are then mounted on a programmable brushing machine that applies controlled filament load, stroke rate, stroke length, and contact time. Removal efficacy is quantified by crystal violet absorbance measurement, viable cell counting, gravimetric mass loss, or confocal laser scanning microscopy with image analysis, and the result is expressed as a percentage of biofilm removed relative to unbrushed controls, aligned with the principles of ISO/TS 16409.

In Vitro Simulated Oral Cleaning Models

Typodont jaws with artificially stained or disclosed surfaces are cleaned using robotic or mechanical brushing systems that reproduce realistic brushing trajectories. High-resolution imaging before and after cleaning enables zone-by-zone calculation of stain coverage reduction, providing a rapid comparative method particularly suitable for toothbrush head design iteration and sonic versus oscillating performance benchmarking.

Clinical Efficacy Trials

Clinical verification is performed using randomized, examiner-blinded, controlled or crossover study designs with an adequate number of enrolled subjects, ethical committee approval, and informed consent. Subjects undergo a supervised plaque accumulation period, typically 24 to 48 hours without oral hygiene, after which plaque is disclosed with an erythrosine-based solution and scored at six sites per tooth by calibrated examiners using the Turesky modification of the Quigley–Hein index on a 0 to 5 scale. Following a standardized product-use period, plaque is re-disclosed and re-scored, and whole-mouth and regional reductions are calculated. Adequate washout intervals between study legs prevent carryover effects in crossover designs.

Data Analysis and Reporting

Plaque removal rate is calculated as the reduction in disclosed plaque score or biomass divided by the baseline value, expressed as a percentage. Statistical analysis employs paired or independent comparison methods appropriate to the study design, with pre-defined significance levels and, where applicable, non-inferiority or superiority margins against a comparator product. Final reports document test conditions, raw scoring data, statistical outcomes, photographic evidence, and conformity conclusions relative to the selected standard.

Applications

Plaque removal efficacy evaluation results are applied across the entire product lifecycle, from research and development to market access and post-launch claim defense. Typical use cases include:

• Regulatory registration and technical dossier support for oral care products in domestic and export markets
• Substantiation of advertising claims such as "removes up to X percent more plaque" in compliance with advertising standards
• Research and development benchmarking of bristle designs, sonic drive systems, and formulation changes against internal or competitor baselines
• Documentation required by e-commerce platforms and retailers for listing efficacy-claimed oral care products
• Quality control and batch consistency verification for high-volume manufacturing
• Support for dental professional recommendations and consumer education materials

FAQ

How long does a plaque removal efficacy evaluation take?

In vitro biofilm and simulated brushing studies are typically completed within four to eight weeks, depending on biofilm maturation time and the number of test conditions. Clinical trials generally require eight to sixteen weeks, accounting for subject recruitment, plaque accumulation periods, washout intervals, and data analysis.

Should I choose an in vitro study or a clinical trial?

In vitro studies are recommended for rapid, low-cost screening during product development and for mechanical comparisons of brush head geometry or abrasive formulations. Clinical trials are necessary when the objective is to support consumer-facing efficacy claims, since they demonstrate performance under real physiological conditions with human subjects. Many manufacturers combine both, using in vitro screening first and confirming final formulations clinically.

What sample quantities should be prepared?

As a general guideline, 20 to 60 units of the finished product in sealed retail packaging are required, along with complete technical documentation including ingredients, materials, operating parameters, and instructions for use. Exact quantities are confirmed in the test plan after the evaluation scope is defined.

Which standards apply to plaque removal testing?

ISO 20126 governs manual toothbrushes, ISO 20127 governs powered toothbrushes, ISO 11609 specifies toothpaste requirements and test methods, and ISO/TS 16409 addresses in vitro biofilm removal assessment. For products sold in China, applicable GB requirements such as GB 19342 for toothbrushes and GB/T 8372 for toothpastes must also be observed. Accredited third-party laboratories will confirm the correct standard combination for the specific product category.

How is the plaque removal rate calculated?

The removal rate equals the baseline plaque measurement minus the post-cleaning measurement, divided by the baseline measurement and multiplied by 100 to express a percentage. In clinical studies, the measurement is typically the summed disclosed plaque index score; in laboratory studies, it is the quantified biofilm biomass or stained coverage area.

Can the test report be used for marketing claims?

Yes. Reports issued by accredited third-party laboratories provide independent, traceable evidence suitable for regulatory submission, retailer verification, and substantiation of advertising claims. The claim wording must accurately reflect the study design, measured endpoint, and statistical outcome as documented in the report.